A person was identified as having a follow-up specimen if name, date of birth and gender were the same as for the initial specimen because no additional patient identifiers were available.
Commercially available human serum from Gemini Bio-Products was used for TIL cultures from initial specimens (specimens #M1 – M26), cryopreservation medium, and TILs undergoing the rapid expansion protocol.
aRespiratory specimen during the 30 days after initial specimen for bacteriologic test was taken.
The initial specimen for one patient (patient 5, Table 1) was tested with a slightly modified IgM antibody assay at a commercial laboratory (12 ).
But other tests on similar specimens did not, prompting some virologists to question whether the initial specimen was contaminated at a lab where earlier tests for SARS had been conducted.
The remaining 7/20 patients went on to have two (5/7 patients) or three (2/7 patients) specimens resected during their surgery because of negative initial specimen imaging (5/7 patients) and/or postexcision neck imaging positive for residual radioactivity (3/7 patients).
The initial specimen was weakly reactive, but two subsequent serum specimens were both nonreactive by enzyme immunoassay.
We expanded the initial specimen set to the total of 33 RP specimens from patients with adenocarcinoma of prostate and 26 BPH control specimens for the interrogation with the six selected FISH probes.
14 days after initial specimen collection (Appendix 9).
Initial specimens on April 4th and April 5th were negative for H7N9.
